Wednesday, February 10, 2010, 3:46am EST - Canadian Markets open in 5 hours and 44 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Daxor Corp. (DXR)

 On Feb 9: 11.00 USD   0.00 (0.00%)  
MORE ON DXR
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
DAXOR CP (AMEX:DXR) Delayed quote dataEdit
Last Trade: 11.00 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 11.00
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 30.00
Day's Range: N/A - N/A
52wk Range: 9.78 - 16.15
Volume: 0
Avg Vol (3m): 11,715.9
Market Cap: 46.75M
P/E (ttm): 6.51
EPS (ttm): 1.69
Div & Yield: 0.35 (3.18%)
Daxor Corp. (DXR)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add DXR to Portfolio   Download Data

HEADLINES
• Presentation of Five Research Reports Involving Daxor's Blood Volume Analyzer at the 39th Annual Society of Critical Care Medicine Conference. Part 2: Direct Blood Volume Measurement Correlated With Improved Survival
Marketwire (Thu, Feb 4)
• 5 Major Research Reports From Studies Using Daxor's Blood Volume Analyzer Presented at the 39th Annual Society of Critical Care Medicine Conference. Part I: Studies on Leaky Capillary Syndrome
Marketwire (Fri, Jan 22)
• Daxor Announces That Medical University of South Carolina in Charleston Purchases Blood Volume Analyzer BVA-100
Marketwire (Tue, Dec 1)
• Daxor Announces Special Year-End Dividend
Marketwire (Mon, Nov 23)
• DAXOR CORP Financials
EDGAR Online Financials (Wed, Nov 18)
• New Star Analyst Rankings for DAXOR CP
StarMine (Sun, Nov 15)
• DAXOR CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 12)
• (NYSE Amex: DXR) Daxor Corporation Announces Third Quarter 2009 Earnings
Marketwire (Thu, Nov 12)
• Daxor Announces That Durham VA Medical Center Acquires BVA-100 Blood Volume Analyzer to Assess Obesity-Related Hemodilution of Serum Cancer Markers
Marketwire (Mon, Oct 19)
• Daxor Announces That Susquehanna Health of Williamsport, PA Acquires BVA-100 Blood Volume Analyzer
Marketwire (Wed, Oct 7)
More Headlines for DXR...
ANALYST
EPS Est (next year) (Dec-09) : 2.08
EPS Est (in 2 years) (Dec-10) : 1.29
Avg Rec (current)*: 2.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Daxor Corporation manufactures and markets blood volume measurement equipment in the United States. Its BVA-100 Blood Volume Analyzer is an instrument that measures human blood volume.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices